Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors
Molecular Weight:
530.5
Purity:
0.9997
CAS Number:
[926037-48-1]
Formula:
C27H21F3N8O
Target:
Apoptosis|||JAK|||STAT|||Bcr-Abl
T2328
* VAT and and shipping costs not included. Errors and price changes excepted
